Facing surgery as we age can be daunting, and the fear of memory loss afterward is a real concern. But what if there were simple ways to help the aging brain cope? Researchers at the University of Illinois Urbana-Champaign have been exploring this very question, and their findings in mice offer a glimmer of hope. They've been investigating how medications might aid in managing memory impairment and recovery after surgery, using noninvasive methods to restore cognitive function. This is especially important, as postoperative cognitive impairment is a relatively common issue among older adults.
In the first study, published in the journal PNAS Nexus, the team tackled the problem of post-surgical cognitive impairment. Did you know that even three months after surgery, 10% of adults over 60 still struggle with learning, memory, and executive function? As lead researcher Uwe Rudolph points out, when you consider the sheer number of surgeries performed on this age group, the impact is substantial.
The researchers focused on propofol, a common anesthetic. While propofol has shown promise in other studies for improving cognition in Alzheimer’s disease models, it's crucial to note that high doses could potentially harm the brain. To get a clearer picture of propofol's effects, the team performed surgery on older mice – an approach that isn't always standard in research. Postdoctoral researcher Rajasekar Nagarajan highlighted the importance of this, explaining that it helps to isolate the effects of the anesthesia from the trauma of the surgery itself.
Their findings were intriguing. Intermittent propofol administration, starting before surgery, significantly improved the mice's performance on various cognitive tasks. Even more remarkable? These positive effects lasted for five days after a single dose, despite propofol being cleared from the body within hours. But here's where it gets interesting... They discovered that propofol increased specific receptors for the neurotransmitter GABA, which is crucial for learning and memory, on the surface of neurons in the hippocampus. They also observed decreased markers for inflammation and cell death. Mice not given propofol didn't show these changes.
In the second study, published in Pharmacology Research and Perspectives, the team turned their attention to age-related memory impairment. They explored the potential of intranasal insulin, as other studies had shown its promise in Alzheimer's disease models. They developed a mouse model to mimic aging in the hippocampus, the pseudo-aged mice. The results were encouraging: the pseudo-aged mice treated with intranasal insulin showed improved performance in tasks related to working memory, recognition memory, and associative memory. The researchers found that the insulin reversed an increase in markers that regulate neural inflammation, thereby reducing inflammation.
And this is the part most people miss... The studies suggest that both propofol and intranasal insulin could offer noninvasive ways to help with cognitive decline. The team is now exploring whether the same receptors that propofol affects are involved in the action of intranasal insulin. They also aim to identify the specific neuron subtype in the hippocampus responsible for these effects.
What do you think about these findings? Could these interventions potentially help humans? Share your thoughts in the comments below!
This work was supported by the National Institute of General Medical Sciences of the U.S. National Institutes of Health.
